Supreme Court Pushes for Robust Regulations in Pharmaceutical Marketing

The Supreme Court emphasized the need for a strong system under the uniform code for pharmaceutical marketing, ensuring that cheated consumers have proper remedies. During a hearing, the court sought measures for consumer complaints and regulation of unethical practices in the pharma industry through the UCPMP 2024.

On Tuesday, the Supreme Court underscored the importance of robust procedures within the uniform code for pharmaceutical marketing, urging that any consumer deceived by unethical practices must have accessible remedies.

The bench, comprising justices Vikram Nath and Sandeep Mehta, called for stringent measures ensuring consumers can conveniently lodge complaints and swiftly hold erring companies accountable.

Additional Solicitor General K M Nataraj mentioned several government policies to regulate the industry, highlighting the UCPMP 2024, which, among other things, bars gift-giving to healthcare professionals. The court prompted further exploration of a statutory regime to strengthen these efforts.

(With inputs from agencies.)